Author:
Dragoi, Andrei-Lucian M.
Sub-Category:
Biology / Medicine
Date Published:
November 17, 2019
Keywords:
ASEA redox supplement (ARS) oral solution, 3-year-old boy, Duchenne muscular dystrophy (DMD), NRF2 selective activation, corticosteroids
Abstract:
This research aims at discovering dietary supplements which may show comparable or even stronger beneficial effects (with less or none adverse effects) than corticosteroids in children with Duchenne Muscular Dystrophy (DMD). This paper presents a case report on the effects of an ionized “saline water” called “ASEA redox Supplement®” (ARS) oral solution in a ~2-year-old boy with DMD from Bucharest, Romania. In vitro studies showed that ARS is a very potent selective NRF2 activator, thus a very potent (indirect) antioxidant: the studies conducted in vivo also support this main pharmacological mechanism of ARS, with no toxicity up to high doses, in contrast with the much more toxic corticosteroids. From the first months of ARS treatment all the rhabdomyolysis markers (with very high initial serum levels) dropped significantly, with no found toxicity.
<<< Back